Intetumumab - CAS 725735-28-4

Intetumumab (CNTO 95) is a fully human anti-α (v) -integrin monoclonal antibody that is a radiosensitizer in xenograft tumor-bearing mice, inhibits tumor growth, and reduces lung metastases in the A549 NSCLC xenograft model.

EGFR, Integrin

Angiogenesis, Tyrosine Kinase/Adaptors, Cytoskeletal Signaling, JAK/STAT signaling

725703

0.976

-20°C

Ice Packs

Inhibitory Antibodies